Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow

Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors

NCT00594295 ·Status: COMPLETED

The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

NCT05629260 ·Status: RECRUITING

Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit

NCT01050946 ·Status: TERMINATED ·Phase: PHASE2

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

NCT04528355 ·Status: RECRUITING

National Marrow Donor Program Long-Term Donor Follow-Up

NCT01362179 ·Status: COMPLETED

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

NCT03500731 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

NCT03000244 ·Status: RECRUITING

Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort)

NCT02344953 ·Status: UNKNOWN

Pulmonary Complications of Allografts

NCT01219972 ·Status: COMPLETED

Study in Adult and Pediatric Patients With HSCT-TMA

NCT04970004 ·Status: WITHDRAWN

Discarded Bone Marrow for Hematology Research

NCT04671212 ·Status: RECRUITING

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Iron Overload in Stem Cell Transplantation

NCT00954720 ·Status: COMPLETED

Photopheresis in GvHD After Hematopoietic Transplantation: Characteristics of the Procedure and of the Cell Product

NCT05718674 ·Status: COMPLETED

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

NCT06715046 ·Status: RECRUITING

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

NCT02934477 ·Status: RECRUITING

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

NCT03904134 ·Status: COMPLETED ·Phase: NA

Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

NCT05290545 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning

NCT00466674 ·Status: COMPLETED ·Phase: PHASE2

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

NCT01162096 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486 ·Status: RECRUITING

Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease

NCT00001872 ·Status: COMPLETED

Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant

NCT03330795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

NCT03412409 ·Status: RECRUITING ·Phase: PHASE2

Role of Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and Mortality After Allogeneic Stem Cell Transplantation

NCT05755633 ·Status: COMPLETED